WhitTier Trust Company’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.3K Sell
222
-2
-0.9% -$144 ﹤0.01% 972
2026
Q1
$15.8K Hold
224
﹤0.01% 957
2025
Q4
$14.1K Sell
224
-18
-7% -$977 ﹤0.01% 973
2025
Q3
$13.3K Sell
242
-4
-2% -$208 ﹤0.01% 971
2025
Q2
$10.6K Hold
246
﹤0.01% 1133
2025
Q1
$9.74K Hold
246
﹤0.01% 1107
2024
Q4
$10K Buy
246
+27
+12% +$1.12K ﹤0.01% 1064
2024
Q3
$8.54K Hold
219
﹤0.01% 1062
2024
Q2
$9.57K Sell
219
-1
-0.5% -$48 ﹤0.01% 1003
2024
Q1
$10.5K Buy
220
+3
+1% +$135 ﹤0.01% 945
2023
Q4
$10.2K Sell
217
-1
-0.5% -$42 ﹤0.01% 940
2023
Q3
$10.4K Buy
218
+42
+24% +$2.29K ﹤0.01% 909
2023
Q2
$10.2K Hold
176
﹤0.01% 949
2023
Q1
$12.6K Buy
+176
New +$14K ﹤0.01% 925

Other funds holding NGVT

WhitTier Trust Company's NGVT Position: Q2 2026 in Review

WhitTier Trust Company reduced its Ingevity (NGVT) stake by 0.89% in Q2 2026, selling an estimated $144 and leaving 222 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #972.

WhitTier Trust Company first reported a position in NGVT in Q1 2023 and has held it in 14 quarters since. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • WhitTier Trust Company held 222 shares of Ingevity worth $16.3K as of Q2 2026.
  • WhitTier Trust Company sold 2 Ingevity shares in Q2 2026, an estimated $144.
  • Ingevity made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #972 holding.
  • WhitTier Trust Company first reported a position in Ingevity in Q1 2023 and has held it in 14 quarters since.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.